戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1    High vs. low daily FA intake was dichotomized at 800mug (median).
2                       METHODS AND Twenty-five patients aged median 12.0 years after repair of tetralogy of Fallot and sim
3                  The mean largest basal diameter was 11 mm (median, 12 mm; range, 3-24 mm), and mean thickness was 5 mm (
4 ability of transition from disease progression to recovery (median 16% per year, 95% uncertainty range 11%-21%).
5  all but three ongoing, and each had 2-16 assessment waves (median = 3) and a follow-up duration of 2-15 y.
6 edian, 12 mm; range, 3-24 mm), and mean thickness was 5 mm (median, 4 mm; range, 1-20 mm).
7 age based on DNA methylation at 329 unique CpG sites, has a median absolute error of 3.33 weeks and has similar propertie
8 tudy included 1418 children (693 girls and 725 boys) with a median age of 27 months (interquartile range, 12-69 months).
9                                                         The median age of the patients was 66 years, and 72% were men; 43
10                  Of 863 patients, 551 (63.9%) were male and median age was 58 years (interquartile range, 51-68 years).
11                                          In these patients, median age was 58 years (IQR 51-62), median number of previou
12 with two or more survey datapoints, the population-weighted median annual rate of change of catastrophic payment incidenc
13 0.787 to 1.08; p = 0.31), whereas those with SPRM above the median derived the greatest benefit (adjusted HR: 0.599; 95%
14 omes are consistent with slow rates of disease progression (median doubling time: 84 days, 95% uncertainty range 62-104)
15 ine had higher-magnitude antibody levels than adults (gp120 median FIs of 15,509 [infants] and 2,290 [adults], P < 0.001;
16 FIs of 15,509 [infants] and 2,290 [adults], P < 0.001; V1V2 median FIs of 23,926 [infants] and 1,538 [adults]; P < 0.001)
17 and infants immunized with the alum/MNrgp120 vaccine (gp120 median fluorescence intensities [FIs] in infants = 7,118 and
18                        Two hundred ninety-seven eyes with a median follow-up of 2.6 years were included.
19 dial infarction, or unstable angina hospitalizations over a median follow-up of 26.1 months.
20                                                    During a median follow-up of 5.0 years (interquartile range, 3.5-6.0 y
21                                                    During a median follow-up of 6.8 years, 256 recipients died, 35 (13.7%
22  were men, and mean eGFR was 94 ml/min per 1.73 m(2) Over a median follow-up of 8 years, 228 (6.4%) cases of incident CKD
23                                                             Median follow-up was 15.9 months (IQR 7.8-22.0) at the data c
24                                                         The median follow-up was 40 months.
25                                          In HD8 (N = 1,064; median follow-up, 153 months), noninferiority of involved-fie
26  those with a SPRM-predicted risk of sudden death below the median had no reduction in mortality with the ICD (adjusted I
27 andidates with MELD scores >/=35 who were transplanted at a median MELD score of 39 (interquartile range [IQR] 37-40) wit
28  in infants = 7,118 and in adults = 11,510, P = 0.070; V1V2 median MFIs of 512 [infants] and 804 [adults], P = 0.50), whe
29 quartile range, -5 to -3.6) with sevoflurane delivered at a median minimum alveolar concentration of 0.45% (interquartile
30 sota Living With Heart Failure score (48 versus 40), higher median N-terminal pro-B-type natriuretic peptide concentratio
31 ation, acupuncture at local versus distal sites may improve median nerve function at the wrist by somatotopically distinc
32 ad 339 OCT sessions over the course of clinical management (median number of OCT scans per eye, 5; range, 1-15).
33     In these patients, median age was 58 years (IQR 51-62), median number of previous lines of therapy was two (2-5), 38
34  of depleted iron stores increased by 7-25 and 2-8 absolute median percentage points for PSC and WRA, respectively, compa
35 ts missing >/=8 consecutive days of ibrutinib had a shorter median PFS vs those missing <8 days (10.9 months vs not reach
36 issue, analyzing data from an influential study reporting a median power of 21% across 49 meta-analyses.
37                                                             Median progression-free survival was 2.8 months (95% CI 2.8-3
38                                                             Median progression-free survival was significantly longer in
39 A total of 52 patients were randomized to the rotating arm (median [range] age, 65 [44-87] years) and 49 patients to the
40  age, 65 [44-87] years) and 49 patients to the control arm (median [range] age, 67 [38-82] years).
41                                                             Median Richmond Agitation Sedation Scale was -4.5 (interquart
42                                                             Median risk estimates from Monte Carlo simulations ranged fro
43  to hospital discharge after OHCA treated with PAD showed a median survival of 40.0% (range, 9.1-83.3).
44                                                         The median SUVmax of 94 tumor lesions was 7.3 (range, 1.6-59.5).
45                                                 After 2 wk, median SUVmax was 6.3 (1.7-62.3), corresponding to a mean dec
46 djusted risk of death for each type of synucleinopathy, the median time from diagnosis to death, and the causes of death.
47                                                         The median time from palliative care consultation to death was 10
48                                                         The median time of day for extubation with an extubation readines
49                                                             Median time to fixation was 15 hours (IQR 7-24 hours) and del
50 1 310 727 examinations (analyzed by using SAS 9.3) provided median values, as well as means and 25th and 75th (DRL) perce

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。